2-amino-3-phosphonopropionic acid has been researched along with Anterior Cerebral Circulation Infarction in 1 studies
2-amino-3-phosphonopropionic acid: metabotropic glutamate receptor antagonist; do not confuse AP-3 used as an abbreviation for this with enhancer-binding protein AP-3 (a trans-activator) or clathrin assembly protein AP-3
2-amino-3-phosphonopropanoic acid : A non-proteinogenc alpha-amino acid that is alanine in which one of the hydrogens of the terminal methyl group has been replaced by a dihydroxy(oxido)-lambda(5)-phosphanyl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cui, D | 1 |
| Xu, J | 1 |
| Xu, Q | 1 |
| Zuo, G | 1 |
1 other study available for 2-amino-3-phosphonopropionic acid and Anterior Cerebral Circulation Infarction
| Article | Year |
|---|---|
DL-2-amino-3-phosphonopropionic acid protects primary neurons from oxygen-glucose deprivation induced injury.
Topics: Alanine; Animals; Apoptosis; Brain Infarction; Cell Survival; Cells, Cultured; Cytochromes c; Down-R | 2017 |